Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Daunorubicin in Older AML Patients
NCT00814164Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2008
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Roswell Park Comprehensive Cancer Center. Started Dec 2008; status: terminated.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00814164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814164.